Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications
about
Cytomegalovirus infection in transplant recipientsAssociation of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical TransmissionImmune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.CMV-specific immune reconstitution following allogeneic stem cell transplantation.Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies.Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation.Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection.Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
P2860
Q26801802-071E60CD-56E2-442B-861E-D83F461AC318Q35760200-1BD14818-BCBB-405B-8E8F-76AC0B4C2A11Q37242592-C7C06EC8-5360-4A9A-A387-F718A099241BQ37504023-91424ECB-1614-41E5-A694-49243A354249Q37509207-53F62CD3-F453-415C-BE55-29769133B62FQ37652611-0F975958-F84D-4060-B482-1575BF0D3B83Q37683007-0432C0ED-310C-446E-B1ED-FB35DE881939Q38547042-6399FB9D-15C9-4B18-AFF5-826A6B8F239AQ38856032-FCE9E71F-3789-42F6-A9FD-4BC23F3EDA46Q38942459-D966C9BC-BDF2-41E3-A277-6A0A05FC7B23Q40163004-C5F0F67D-05F6-4378-B105-DFA652F63A38Q40232782-ED228FA3-0FBF-4A78-9C3A-55C349D9BBF4Q40355635-C42D29F7-74EC-45AD-952A-62095515B7A2Q41684129-9A5153C3-8126-494E-87DB-6F901661EE2AQ43577477-D6A94F6C-6555-41F5-ABF0-0EE8FDA1769DQ47136178-D686CA01-576D-4E49-8DE4-602868EF0364Q47557661-F5F9F34D-4784-4723-AA0C-D4DB3349CA07Q52367953-2C726CF9-7139-4860-8741-49679E2066B9Q57053200-634153DE-9CB3-4C86-BBBC-9D4EF73E7A33
P2860
Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical assessment of anti-vi ...... th CMV infection complications
@en
Clinical assessment of anti-vi ...... h CMV infection complications.
@nl
type
label
Clinical assessment of anti-vi ...... th CMV infection complications
@en
Clinical assessment of anti-vi ...... h CMV infection complications.
@nl
prefLabel
Clinical assessment of anti-vi ...... th CMV infection complications
@en
Clinical assessment of anti-vi ...... h CMV infection complications.
@nl
P2093
P2860
P50
P1433
P1476
Clinical assessment of anti-vi ...... th CMV infection complications
@en
P2093
Ashish K Misra
Glen A Kennedy
James A Morton
Jason P Butler
Linda I Jones
Simon T Durrant
Susan Walker
Tania Crough
P2860
P304
P356
10.1371/JOURNAL.PONE.0074744
P407
P577
2013-10-11T00:00:00Z